Christine  Houston net worth and biography

Christine Houston Biography and Net Worth

Insider of Express Scripts
Chris Houston leads all core operations, including pharmacies, call centers and client services. She joined the company in 1997 and has held numerous leadership positions in information technology, our specialty pharmacy business and operations. Before being appointed to her current position, Chris most recently served as Senior Vice President ofSupply Chain, where she oversaw Express Scripts’ contracting with pharmaceutical companies and retail pharmacies. She holds a bachelor's degree in computer science from Saint Louis University, where she graduated with distinction. Chris reports to Tim Wentworth.

What is Christine Houston's net worth?

The estimated net worth of Christine Houston is at least $10.24 million as of August 10th, 2018. Ms. Houston owns 110,908 shares of Express Scripts stock worth more than $10,240,136 as of April 23rd. This net worth approximation does not reflect any other investments that Ms. Houston may own. Learn More about Christine Houston's net worth.

How old is Christine Houston?

Ms. Houston is currently 55 years old. There are 4 older executives and no younger executives at Express Scripts. Learn More on Christine Houston's age.

How do I contact Christine Houston?

The corporate mailing address for Ms. Houston and other Express Scripts executives is ONE EXPRESS WAY, SAINT LOUIS MO, 63121. Express Scripts can also be reached via phone at 314-996-0900 and via email at [email protected]. Learn More on Christine Houston's contact information.

Has Christine Houston been buying or selling shares of Express Scripts?

Christine Houston has not been actively trading shares of Express Scripts during the last quarter. Most recently, Christine Houston sold 12,898 shares of the business's stock in a transaction on Friday, August 10th. The shares were sold at an average price of $85.00, for a transaction totalling $1,096,330.00. Following the completion of the sale, the insider now directly owns 110,908 shares of the company's stock, valued at $9,427,180. Learn More on Christine Houston's trading history.

Who are Express Scripts' active insiders?

Express Scripts' insider roster includes Phyllis Anderson (VP), James Havel (Exec. VP & CFO ), Christine Houston (Insider), Christopher McGinnis (VP), Everett Neville (VP), Glen Stettin (VP), and Timothy Wentworth (CEO). Learn More on Express Scripts' active insiders.

Christine Houston Insider Trading History at Express Scripts

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/10/2018Sell12,898$85.00$1,096,330.00110,908View SEC Filing Icon  
6/13/2018Sell10,000$82.28$822,800.00108,010View SEC Filing Icon  
3/15/2018Sell19,889$76.69$1,525,287.41View SEC Filing Icon  
12/15/2017Sell10,104$70.08$708,088.3287,400View SEC Filing Icon  
See Full Table

Christine Houston Buying and Selling Activity at Express Scripts

This chart shows Christine Houston's buying and selling at Express Scripts by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Express Scripts Company Overview

Express Scripts logo
Express Scripts Holding Company operates as a pharmacy benefit management (PBM) company in the United States and Canada. The company's PBM segment offers clinical solutions; and specialized pharmacy care, home delivery and specialty pharmacy, retail network pharmacy administration, benefit design consultation, drug utilization review, drug formulary management, public exchange, administration of group purchasing organization, and digital consumer health and drug information services. This segment also provides Medicare, Medicaid, and health insurance marketplace products; Express Scripts SafeGuardRx, a suite of solutions targeting the therapy classes that pose clinical challenges and budgetary threat to its clients; and Inside Rx, a program that provide affordable access to medication for uninsured and underinsured individuals. Its Other Business Operations segment distributes specialty pharmaceuticals and medical supplies, including injectable and infusible pharmaceuticals and medications to treat specialty and rare/orphan diseases. This segment also provides medical benefit management solutions for radiology, cardiology, musculoskeletal disorders, sleep disorders, post-acute care, genetic lab, specialty pharmacy, and medical oncology. The company serves managed care organizations, health insurers, third-party administrators, employers, union-sponsored benefit plans, workers' compensation plans, government health programs, providers, clinics, hospitals, and others. As of December 31, 2017, it operated 4 automated dispensing home delivery pharmacies; 1 non-automated dispensing home delivery pharmacy; 7 non-dispensing order processing centers; 5 patient contact centers; 9 specialty home delivery pharmacies; and 34 specialty branch pharmacies. The company was formerly known as Aristotle Holding, Inc. and changed its name to Express Scripts Holding Company in April 2012. Express Scripts Holding Company was founded in 1986 and is headquartered in Saint Louis, Missouri.
Read More

Today's Range

Now: $92.33
Low: $92.11
High: $95.87

50 Day Range

MA: $92.33
Low: $92.33
High: $92.33

2 Week Range

Now: $92.33
Low: $66.93
High: $101.73

Volume

31,612,912 shs

Average Volume

6,636,970 shs

Market Capitalization

$52.06 billion

P/E Ratio

13.00

Dividend Yield

N/A

Beta

0.88